12th orphan drugs & rare diseases global congress 2020 Europe, London

Idiopathic Pulmonary Fibrosis: 5 Things to Know

Report on the ATTRACT study

Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic

Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients

Untangling the dualistic components of the RAS in PF the Yin and Yang